{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:38:10Z","timestamp":1793828290990,"version":"4.6.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL136423"],"award-info":[{"award-number":["R01 HL136423"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016419","name":"Breast Cancer Research Foundation of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cytogfr.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:33:51Z","timestamp":1760538831000},"page":"96-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Arteriolar angiogenesis: implications in anti-angiogenic immunotherapy for pancreatic cancers"],"prefix":"10.1016","volume":"86","author":[{"given":"Adam W.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-6816","authenticated-orcid":false,"given":"Bin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s42003-021-02308-6","article-title":"Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid\/protein kinase d signaling","volume":"4","author":"Jiang","year":"2021","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI39837","article-title":"ERK1\/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish","volume":"120","author":"Ren","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"Pt 2","key":"10.1016\/j.cytogfr.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semcancer.2022.09.006","article-title":"Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1","volume":"86","author":"Lawler","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","article-title":"Angiogenesis: where do we stand now?","volume":"111","author":"Simons","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.002_bib5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/jcm8111980","article-title":"Heterogeneity of vascular endothelial cells, de novo arteriogenesis and therapeutic implications in pancreatic neuroendocrine tumors","volume":"8","author":"Ren","year":"2019","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2006.tb00290.x","article-title":"Arteriogenesis versus angiogenesis: similarities and differences","volume":"10","author":"Heil","year":"2006","journal-title":"J. Cell Mol. Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.002_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Simons","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.002_bib9","first-page":"333","article-title":"Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle","volume":"17","author":"Gabhann","year":"2010","journal-title":"Microcirculation"},{"issue":"23","key":"10.1016\/j.cytogfr.2025.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233885","article-title":"Protein kinase D1 signaling in cancer stem cells with Epithelial-Mesenchymal plasticity","volume":"11","author":"Guo","year":"2022","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.cytogfr.2025.10.002_bib11","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1158\/0008-5472.CAN-11-1693","article-title":"Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy","volume":"71","author":"Sitohy","year":"2011","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ncb3555","article-title":"Dll4 and notch signalling couples sprouting angiogenesis and artery formation","volume":"19","author":"Pitulescu","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41580-024-00825-w","article-title":"Microenvironmental determinants of endothelial cell heterogeneity","volume":"26","author":"Gomez-Salinero","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030381","article-title":"Angiogenesis in pancreatic cancer: Pre-Clinical and clinical studies","volume":"11","author":"Annese","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib17","article-title":"Linking tumour angiogenesis and tumour immunity","author":"Kabir","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2023.11.002","article-title":"Reprogramming endothelial cells to empower cancer immunotherapy","volume":"30","author":"Cleveland","year":"2024","journal-title":"Trends Mol. Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.002_bib19","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/0008-5472.CAN-04-3759","article-title":"Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2","volume":"65","author":"Wada","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/jcb.21523","article-title":"Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling","volume":"102","author":"Semenza","year":"2007","journal-title":"J. Cell Biochem"},{"issue":"5459","key":"10.1016\/j.cytogfr.2025.10.002_bib21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1126\/science.287.5459.1820","article-title":"Gridlock, an HLH gene required for assembly of the aorta in zebrafish","volume":"287","author":"Zhong","year":"2000","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.cytogfr.2025.10.002_bib22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cub.2006.05.046","article-title":"Artery\/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase\/ERK signaling","volume":"16","author":"Hong","year":"2006","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1300021110","article-title":"Innate immunity receptor CD36 promotes cerebral amyloid angiopathy","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7635","key":"10.1016\/j.cytogfr.2025.10.002_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/ATVBAHA.116.307421","article-title":"LPA\/PKD-1-FoxO1 signaling axis mediates endothelial cell CD36 transcriptional repression and proangiogenic and proarteriogenic reprogramming","volume":"36","author":"Ren","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1-2","key":"10.1016\/j.cytogfr.2025.10.002_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11010-018-3286-z","article-title":"VEGF\/PKD-1 signaling mediates arteriogenic gene expression and angiogenic responses in reversible human microvascular endothelial cells with extended lifespan","volume":"446","author":"Best","year":"2018","journal-title":"Mol. Cell Biochem"},{"issue":"22","key":"10.1016\/j.cytogfr.2025.10.002_bib27","first-page":"6036","article-title":"Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1\u2013dependent signaling pathway","volume":"117","author":"Ren","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"17","key":"10.1016\/j.cytogfr.2025.10.002_bib28","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1182\/blood-2010-09-305284","article-title":"Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase","volume":"117","author":"Kazerounian","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cytogfr.2025.10.002_bib29","doi-asserted-by":"crossref","first-page":"22550","DOI":"10.18632\/oncotarget.15123","article-title":"Diet-induced obesity links to ER positive breast cancer progression via LPA\/PKD-1-CD36 signaling-mediated microvascular remodeling","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"147","key":"10.1016\/j.cytogfr.2025.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.3791\/59624","article-title":"Translating ribosome affinity purification (TRAP) for RNA isolation from endothelial cells in vivo","author":"Moran","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib32","first-page":"178","article-title":"Regulation of tumor angiogenesis by thrombospondin-1","volume":"1765","author":"Ren","year":"2006","journal-title":"Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1091\/mbc.e09-07-0591","article-title":"Vascular endothelial growth factor: much more than an angiogenesis factor","volume":"21","author":"Senger","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.cytogfr.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med"},{"issue":"4587","key":"10.1016\/j.cytogfr.2025.10.002_bib36","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem Biophys. Res Commun."},{"issue":"_16","key":"10.1016\/j.cytogfr.2025.10.002_bib38","article-title":"Abstract 614: ERK signaling: the pivotal regulator of arterial differentiation","volume":"116","author":"Ren","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.devcel.2013.03.019","article-title":"The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis","volume":"25","author":"Lanahan","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2025.10.002_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcell.2016.00037","article-title":"Protein kinase D1 signaling in angiogenic gene expression and VEGF-Mediated angiogenesis","volume":"4","author":"Ren","year":"2016","journal-title":"Front Cell Dev. Biol."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.10.002_bib42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/ars.2017.7166","article-title":"Ultrafine particle exposure reveals the importance of FOXO1\/Notch activation complex for vascular regeneration","volume":"28","author":"Baek","year":"2018","journal-title":"Antioxid. Redox Signal"},{"issue":"15","key":"10.1016\/j.cytogfr.2025.10.002_bib43","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0813061106","article-title":"VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-023-01539-9","article-title":"VEGF-B prevents excessive angiogenesis by inhibiting FGF2\/FGFR1 pathway","volume":"8","author":"Lee","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"Pt 3","key":"10.1016\/j.cytogfr.2025.10.002_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2022.03.011","article-title":"The impact of VEGF on cancer metastasis and systemic disease","volume":"86","author":"Yang","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib47","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.immuni.2025.02.017","article-title":"Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME","volume":"58","author":"Benmebarek","year":"2025","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.002_bib48","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.cell.2025.02.005","article-title":"CXCL12 drives natural variation in coronary artery anatomy across diverse populations","volume":"188","author":"Rios Coronado","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cytogfr.2023.10.003","article-title":"An emerging paradigm of CXCL12 involvement in the metastatic cascade","volume":"75","author":"Anastasiadou","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.10.002_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cytogfr.2025.10.002_bib51","article-title":"The influence of SDF-1 (CXCL12) gene in health and disease: a review of literature","author":"Biyani","year":"2024","journal-title":"Biophys. Rev. Ger."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib52","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2004-07-2563","article-title":"The role of CXCL12 in the organ-specific process of artery formation","volume":"105","author":"Ara","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib53","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ncb3574","article-title":"Endothelial notch signalling limits angiogenesis via control of artery formation","volume":"19","author":"Hasan","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cytogfr.2025.10.002_bib54","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1038\/ncomms6758","article-title":"Arteries are formed by vein-derived endothelial tip cells","volume":"5","author":"Xu","year":"2014","journal-title":"Nat. Commun."},{"issue":"6685","key":"10.1016\/j.cytogfr.2025.10.002_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.cytogfr.2025.10.002_bib56","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200909","article-title":"CXCL12 defines lung endothelial heterogeneity and promotes distal vascular growth","volume":"149","author":"Chandrasekaran","year":"2022","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.devcel.2015.03.026","article-title":"The CXCL12\/CXCR4 axis plays a critical role in coronary artery development","volume":"33","author":"Ivins","year":"2015","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s43018-024-00780-7","article-title":"Milestones in tumor vascularization and its therapeutic targeting","volume":"5","author":"De Palma","year":"2024","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib59","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1038\/s41467-022-33324-7","article-title":"Endothelial cell cycle state determines propensity for arterial-venous fate","volume":"13","author":"Chavkin","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.002_bib60","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.stem.2024.11.003","article-title":"Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip","volume":"31","author":"Georgescu","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.002_bib61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"7940","key":"10.1016\/j.cytogfr.2025.10.002_bib62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05475-6","article-title":"Ras drives malignancy through stem cell crosstalk with the microenvironment","volume":"612","author":"Yuan","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.002_bib63","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.trecan.2023.06.010","article-title":"Perivascular niches: critical hubs in cancer evolution","volume":"9","author":"Nowosad","year":"2023","journal-title":"Trends Cancer"},{"issue":"8_ement","key":"10.1016\/j.cytogfr.2025.10.002_bib64","doi-asserted-by":"crossref","first-page":"LB150","DOI":"10.1158\/1538-7445.AM2023-LB150","article-title":"Abstract LB150: endothelial protein kinase D1 signaling induces development of aggressive cancer stem-like cells for breast cancer progression and lung metastasis","volume":"83","author":"Akil","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2019.04.003","article-title":"Intra-Tumoral metabolic zonation and resultant phenotypic diversification are dictated by blood vessel proximity","volume":"30","author":"Kumar","year":"2019","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2353\/ajpath.2009.090095","article-title":"Development of arterial blood supply in experimental liver metastases","volume":"175","author":"Dezso","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/path.4464","article-title":"Mechanism of tumour vascularization in experimental lung metastases","volume":"235","author":"Szabo","year":"2015","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/PPO.0000000000000124","article-title":"Tumor stroma, tumor blood vessels, and antiangiogenesis therapy","volume":"21","author":"Dvorak","year":"2015","journal-title":"Cancer J."},{"issue":"14","key":"10.1016\/j.cytogfr.2025.10.002_bib69","doi-asserted-by":"crossref","first-page":"22550","DOI":"10.18632\/oncotarget.15123","article-title":"Diet-induced obesity links to ER positive breast cancer progression via LPA\/PKD-1-CD36 signaling-mediated microvascular remodeling","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib70","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI57322","article-title":"Endothelial HIF-2alpha regulates murine pathological angiogenesis and revascularization processes","volume":"122","author":"Skuli","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.10.002_bib71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med"},{"issue":"7586","key":"10.1016\/j.cytogfr.2025.10.002_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature17040","article-title":"Angiocrine functions of organ-specific endothelial cells","volume":"529","author":"Rafii","year":"2016","journal-title":"Nature"},{"issue":"6824","key":"10.1016\/j.cytogfr.2025.10.002_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib74","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib75","first-page":"102","article-title":"Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma","volume":"6","author":"Rempel","year":"2000","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res"},{"issue":"52","key":"10.1016\/j.cytogfr.2025.10.002_bib77","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416909121","article-title":"CXCL12 restricts tumor growth by suppressing the ras, ERK1\/2, c-Myc, and the immune checkpoint PD-L1 pathways","volume":"121","author":"Kravtsova-Ivantsiv","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7122","key":"10.1016\/j.cytogfr.2025.10.002_bib78","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature05355","article-title":"Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis","volume":"444","author":"Noguera-Troise","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ccell.2016.11.010","article-title":"Molecular checkpoint decisions made by subverted vascular niche transform indolent tumor cells into chemoresistant cancer stem cells","volume":"31","author":"Cao","year":"2017","journal-title":"Cancer Cell"},{"issue":"7473","key":"10.1016\/j.cytogfr.2025.10.002_bib80","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.cytogfr.2025.10.002_bib81","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib82","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/s41467-020-18860-4","article-title":"Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat. Commun."},{"issue":"7325","key":"10.1016\/j.cytogfr.2025.10.002_bib83","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09624","article-title":"Glioblastoma stem-like cells give rise to tumour endothelium","volume":"468","author":"Wang","year":"2010","journal-title":"Nature"},{"issue":"7325","key":"10.1016\/j.cytogfr.2025.10.002_bib84","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03698-4","article-title":"PD-L1 and the Dawn of modern cancer immunotherapy","author":"Chen","year":"2025","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.002_bib86","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib87","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-019-0974-6","article-title":"Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment","volume":"18","author":"Yi","year":"2019","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.002_bib88","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med"},{"issue":"6219","key":"10.1016\/j.cytogfr.2025.10.002_bib89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","article-title":"Induction of angiogenesis during the transition from hyperplasia to neoplasia","volume":"339","author":"Folkman","year":"1989","journal-title":"Nature"},{"issue":"6015","key":"10.1016\/j.cytogfr.2025.10.002_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","article-title":"Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes","volume":"315","author":"Hanahan","year":"1985","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.10.002_bib91","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","article-title":"A Cross-Species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics","volume":"5","author":"Sadanandam","year":"2015","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.10.002_bib92","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/0008-5472.CAN-08-2940","article-title":"A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR","volume":"69","author":"Ren","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/stem.1716","article-title":"Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression","author":"Hale","year":"2014","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib94","article-title":"Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy","volume":"4","author":"Subramanian","year":"2023","journal-title":"Cell Rep. Med"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.10.002_bib95","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib96","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib97","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1038\/s41467-022-33991-6","article-title":"PD-L1-directed PlGF\/VEGF blockade synergizes with chemotherapy by targeting CD141(+) cancer-associated fibroblasts in pancreatic cancer","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib99","doi-asserted-by":"crossref","first-page":"1171794","DOI":"10.3389\/fonc.2023.1171794","article-title":"Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells","volume":"13","author":"Ebeling","year":"2023","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.10.002_bib100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","article-title":"Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal","volume":"20","author":"Sounni","year":"2014","journal-title":"Cell Metab."},{"issue":"Pt B","key":"10.1016\/j.cytogfr.2025.10.002_bib102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2023.05.008","article-title":"Emerging functions of thrombospondin-1 in immunity","volume":"155","author":"Kaur","year":"2024","journal-title":"Semin Cell Dev. Biol."},{"issue":"26","key":"10.1016\/j.cytogfr.2025.10.002_bib103","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.3748\/wjg.v29.i26.4174","article-title":"Progress in immunotherapy for neuroendocrine neoplasm of the digestive system","volume":"29","author":"Pan","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib104","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","article-title":"Current and future immunotherapeutic approaches in pancreatic cancer treatment","volume":"17","author":"Farhangnia","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib105","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jamaoncol.2022.0212","article-title":"Assessment of clinical response following atezolizumab and bevacizumab treatment in patients with neuroendocrine tumors: a nonrandomized clinical trial","volume":"8","author":"Halperin","year":"2022","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13496","article-title":"Phase Ib\/II study of pembrolizumab with lanreotide depot for advanced, progressive gastroenteropancreatic neuroendocrine tumors (PLANET)","volume":"37","author":"Morse","year":"2025","journal-title":"J. Neuroendocr."},{"issue":"385","key":"10.1016\/j.cytogfr.2025.10.002_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.002_bib108","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1136\/gutjnl-2020-321016","article-title":"Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours","volume":"70","author":"Young","year":"2021","journal-title":"Gut"},{"issue":"50","key":"10.1016\/j.cytogfr.2025.10.002_bib109","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6230","key":"10.1016\/j.cytogfr.2025.10.002_bib110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.002_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002505","article-title":"Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects","volume":"9","author":"Suarez-Carmona","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cytogfr.2025.10.002_bib112","doi-asserted-by":"crossref","first-page":"1352484","DOI":"10.3389\/fimmu.2024.1352484","article-title":"Novel insights into notch signaling in tumor immunity: potential targets for cancer immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib113","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-021-01133-y","article-title":"Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.10.002_bib114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1535370220960675","article-title":"Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia","volume":"246","author":"Li","year":"2021","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"18","key":"10.1016\/j.cytogfr.2025.10.002_bib115","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1158\/0008-5472.CAN-04-0401","article-title":"Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies","volume":"64","author":"Bocci","year":"2004","journal-title":"Cancer Res"},{"issue":"ement_1","key":"10.1016\/j.cytogfr.2025.10.002_bib116","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1677\/erc.1.00999","article-title":"Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy","volume":"12","author":"Bianco","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib117","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ijrobp.2003.09.091","article-title":"Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies","volume":"58","author":"Viloria-Petit","year":"2004","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.10.002_bib119","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med"},{"issue":"22","key":"10.1016\/j.cytogfr.2025.10.002_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212038","article-title":"Predicting and monitoring immune checkpoint inhibitor therapy using artificial intelligence in pancreatic cancer","volume":"25","author":"Yu","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.10.002_bib121","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70246","article-title":"Coronary blood vessels from distinct origins converge to equivalent states during mouse and human development","volume":"10","author":"Phansalkar","year":"2021","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib122","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","article-title":"Vascular endothelial cell development and diversity","volume":"20","author":"Trimm","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.10.002_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800198","article-title":"Veins and arteries build hierarchical branching patterns differently: Bottom-Up versus Top-Down","volume":"41","author":"Red-Horse","year":"2019","journal-title":"Bioessays"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib124","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.stem.2018.07.011","article-title":"Endothelial regeneration of large vessels is a biphasic process driven by local cells with distinct proliferative capacities","volume":"23","author":"McDonald","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"16","key":"10.1016\/j.cytogfr.2025.10.002_bib125","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.121.054071","article-title":"Role of venous endothelial cells in developmental and pathologic angiogenesis","volume":"144","author":"Lee","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.10.002_bib126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.053047","article-title":"Defective Flow-Migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia","volume":"144","author":"Park","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.10.002_bib127","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41422-022-00615-z","article-title":"Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals","volume":"32","author":"Hou","year":"2022","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.10.002_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119653","article-title":"Protein kinase d (PKD) on the crossroad of lipid absorption, synthesis and utilization","volume":"1871","author":"Wit","year":"2024","journal-title":"Biochim Biophys. Acta Mol. Cell Res"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:30:17Z","timestamp":1781235017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":128,"alternative-id":["S1359610125001364"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.10.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arteriolar angiogenesis: implications in anti-angiogenic immunotherapy for pancreatic cancers","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}